Presenter: Asim V. Farooq, MD Date: 7:30 p.m. ET Thursday, Dec. 5 Antibody-drug conjugates (ADCs) are a new and growing class of targeted cancer drugs. These drugs commonly cause ocular surface toxicity. This webinar will review what is currently known about ADC-associated ocular surface toxicity and how cornea specialists should approach these patients. Register today

Presenter: Christopher Sales, MD, MPH Date: 7:30 p.m. ET Tuesday, Feb. 11 Christopher Sales, MD, MPH will walk us through his approach to doing DMEK in complex eyes using an endothelium-in pull through technique. Register today